Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Coronavirus channel feed
Novartis' biotech partner admits PhIII Covid-19 defeat for stem cell therapy, triggering extension of $1.2B+ deal close
5 years ago
R&D
In historic vote, mRNA vaccines go 2 and 0 as FDA experts unanimously back Moderna's Covid-19 vaccine
5 years ago
R&D
GlaxoSmithKline, Vir look to succeed where Lilly failed with NIH antibody study in hospitalized Covid-19 patients
5 years ago
R&D
'A precedent you might not want to set.' FDA-invited expert blasts Moderna unblinding plan as adcomm gets underway
5 years ago
Covid-19 roundup: FDA gives OK to use extra doses in Pfizer/BioNTech vaccine vials; Sinopharm's Peru trial to resume
5 years ago
EXCLUSIVE: AstraZeneca makes tough unblinding call, grappling with a vaccine rollout that threatens to impair their embattled PhIII
5 years ago
Covid-19 roundup: It could be years before vaccines reach some countries — report; EMA pushes up Pfizer vaccine panel to Dec 21
5 years ago
FDA docs give Moderna green light, while spotlighting differences with Pfizer
5 years ago
FDA+
Covid-19 roundup: US negotiating for more doses of Pfizer vaccine; Brazil delays efficacy readout for Sinovac vaccine
5 years ago
Gottlieb op-ed: Manufacturers need to ramp up production of antibodies as 'Covid insurance policy'
5 years ago
Manufacturing
Covid-19 roundup: Trump walks back plans to prioritize White House staff for vaccine; AstraZeneca drops subgroup of children from vaccine trial — report
5 years ago
FDA authorizes Pfizer-BioNTech Covid-19 vaccine
5 years ago
Trump officials double up on Moderna vaccine supply, eyeing H1 mRNA campaign as Big Pharmas stumble
5 years ago
A Covid-19 vaccine OK is imminent, but Trump continues unprecedented assault on the FDA
5 years ago
An EUA is coming, FDA tells Pfizer
5 years ago
FDA+
Covid-19 roundup: AstraZeneca team finds a surprise Covid-19 vaccine partner; Biogen conference linked to 300K cases
5 years ago
Sanofi, GlaxoSmithKline hit with a major delay on Covid-19 vaccine program as their first jab flops in older adults
5 years ago
R&D
Advisory committee votes 17-4 to recommend FDA authorize Pfizer-BioNTech vaccine, opening door to rapid EUA
5 years ago
FDA+
University of Queensland shuts down Covid-19 vaccine program after observing interference with HIV tests
5 years ago
Covid-19 roundup: Moderna begins PhII/III vaccine study in adolescents; Pfizer and BioNTech's vaccine gets an OK in Canada as the FDA meets to discuss emergency use
5 years ago
Hackers steal Pfizer, BioNTech data in EMA breach as cybersecurity attacks heat up
5 years ago
AstraZeneca's vaccine hit its first roadblock with Indian regulators. Will lingering doubts derail its plans elsewhere?
5 years ago
FDA+
Covid-19 roundup: UAE claims Sinopharm vaccine 86% effective, but details are scant; India reportedly rejects AstraZeneca's vaccine, while UK conducts 'all encompassing' review
5 years ago
AstraZeneca publishes interim vaccine data in Lancet, reveals 10 hospitalizations, 1 death in pivotal control arms
5 years ago
FDA+
First page
Previous page
36
37
38
39
40
41
42
Next page
Last page